PTAB designates decision precedential

Published on: 07/10/2019 11:23 AM

[[VIEW_THIS]]

Divider

Patent Trial and Appeal Board

USPTO-footer-graphic

PTAB designates decision precedential

Focal Therapeutics, Inc. v. SenoRx, Inc., Case IPR2014-00116 (PTAB July 21, 2014) (Paper 19)
This order advises that, although counsel may not confer with a witness during cross-examination, counsel may confer with a witness after cross-examination has concluded and before redirect begins.

This decision can be found on the PTAB Precedential and Informative Decisions page of the USPTO website.

 
facebook
twitter
youtube
linkedin
 

Stay connected with the USPTO by subscribing to regular email updates.

Visit our subscription center at www.uspto.gov/subscribe to update or change your email preferences.

This email was sent from an unmonitored mailbox. To contact us, please visit our website www.uspto.gov/about/contacts. To ensure that you continue to receive our news and notices, please modify your email filters to allow mail from subscriptioncenter@subscriptions.uspto.gov.

uspto